Lupus breakthrough sparks hope in a frustrating field

AstraZeneca has presented new positive clinical trial results for anifrolumab, an investigational monoclonal antibody that is under development for the treatment of moderate to severe lupus. Abi Millar speaks to Dr Richard Furie, principal investigat …
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news